Testing a new pneumococcal vaccine in healthy babies
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests an experimental pneumococcal vaccine in healthy infants. It involves three shots during infancy and a booster around 12-15 months to see if it is safe and how the body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be about 2 months old (between 6 weeks and 3 months).
- Your baby must have been born full-term (at least 37 weeks) and weigh more than 5.5 pounds at birth.
- Your baby must be generally healthy, with no serious medical conditions like immune problems, major birth defects, or seizures.
- Your baby cannot have already received a pneumococcal vaccine.
- Your baby cannot have severe allergies to any vaccine ingredient or to latex.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pneumococcal vaccine as a booster shot in toddlers who already got a full primary series. It aims to see if the booster is safe and produces a strong immune response.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
Hear when a new Pneumonia, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.